Mesenchymal stem cells in the human corneal limbal stroma

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 9, 2012, Pages 5109-5116

  Branch, Matthew James ^a   Hashmani, Khurram ^a   Dhillon, Permesh ^a   Jones, D Rhodri E ^a   Dua, Harminder Singh ^a   Hopkinson, Andrew ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; ADAPALENE; ALDEHYDE DEHYDROGENASE; ALPHA2 INTEGRIN; ALPHA4 INTEGRIN; ALPHA5 INTEGRIN; ALPHA6 INTEGRIN; BETA1 INTEGRIN; BREAST CANCER RESISTANCE PROTEIN; CD11B ANTIGEN; CD133 ANTIGEN; CD19 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; COMPLEMENT COMPONENT C3B RECEPTOR; CYTOKERATIN 12; CYTOKERATIN 14; CYTOKERATIN 19; CYTOKERATIN 3; ENDOGLIN; HERMES ANTIGEN; HLA ANTIGEN; HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; KERATOCAN; MICROSOMAL AMINOPEPTIDASE; THY 1 ANTIGEN; UNINDEXED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VIMENTIN;

ARTICLE; CELL ADHESION; CELL DIFFERENTIATION; CELL LINEAGE; CELL SELECTION; CONTROLLED STUDY; CORNEA STROMA; FLOW CYTOMETRY; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ALDEHYDE DEHYDROGENASE; ANTIGENS, CD34; BIOLOGICAL MARKERS; CELL ADHESION; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CORNEAL STROMA; FETAL STEM CELLS; FLOW CYTOMETRY; GESTATIONAL AGE; HUMANS; LIMBUS CORNEAE; LIVER; MESENCHYMAL STEM CELLS; PHENOTYPE; PROTEOGLYCANS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84864719775     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.11-8673     Document Type: Article

References (57)

1. West-Mays JA, Dwivedi DJ. The keratocyte: corneal stromal cell with variable repair phenotypes. Int J Biochem Cell Biol. 2006;38:1625-1631.
2. Du Y, Funderburgh ML, Mann MM, SundarRaj N, Funderburgh JL. Multipotent stem cells in human corneal stroma. Stem Cells. 2005;23:1266-1275.
3. Fini ME, Stramer BM. How the cornea heals: cornea-specific repair mechanisms affecting surgical outcomes. Cornea. 2005; 24:S2-S11.
4. Hassell JR, Birk DE. The molecular basis of corneal transparency. Exp Eye Res. 1010;91:326-335.
5. Funderburgh JL. Keratan sulfate: structure, biosynthesis, and function. Glycobiology. 2000;10:951-958.
6. Pei Y, Reins RY, McDermott AM. Aldehyde dehydrogenase (ALDH) 3A1 expression by the human keratocyte and its repair phenotypes. Exp Eye Res. 2006;83:1063-1073.
7. Perrella G, Brusini P, Spelat R, et al. Expression of haematopoietic stem cell markers, CD133 and CD34 on human corneal keratocytes. Br J Ophthalmol. 2007;91:94-99.
8. Jester JV. Corneal crystallins and the development of cellular transparency. Semin Cell Dev Biol. 2008;19:82-93.
9. Joseph A, Hossain P, Jham S, et al. Expression of CD34 and L-selectin on human corneal keratocytes. Invest Ophthalmol Vis Sci. 2003;44:4689-4692.
10. Jester JV, Petroll WM, Cavanagh HD. Corneal stromal wound healing in refractive surgery: the role of myofibroblasts. Prog Retin Eye Res. 1999;18:311-356.
11. Funderburgh JL, Mann MM, Funderburgh ML. Keratocyte phenotype mediates proteoglycan structure: a role for fibroblasts in corneal fibrosis. J Biol Chem. 2003;278:45629-45637.
12. Kawakita T, Espana EM, He H, et al. Keratocan expression of murine keratocytes is maintained on amniotic membrane by down-regulating transforming growth factor-beta signaling. J Biol Chem. 2005;280:27085-27092.
13. Espana EM, Kawakita T, Liu CY, Tseng SC. CD-34 expression by cultured human keratocytes is downregulated during myofi-broblast differentiation induced by TGF-beta1. Invest Ophthal Vis Sci. 2004;45:2985-2991.
14. Hoar RM. Embryology of the eye. Environ Health Perspect. 1982;44:31-34.
15. Polisetty N, Fatima A, Madhira SL, Sangwan VS, Vemuganti GK. Mesenchymal cells from limbal stroma of human eye. Mol Vis. 2008;14:431-442.
16. Choong PF, Mok PL, Cheong SK, Then KY. Mesenchymal stromal cell-like characteristics of corneal keratocytes. Cyto-therapy. 2007;9:252-258.
17. Barbosa FL, et al. Corneal myofibroblast generation from bone marrow-derived cells. Exp Eye Res. 91:92-96.
18. Sosnova M, Bradl M, Forrester JV. CD34{thorn} corneal stromal cells are bone marrow-derived and express hemopoietic stem cell markers. Stem Cells. 2005;23:507-515.
19. Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells: The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315-317.
20. Wakitani S, Goto T, Pineda SJ, et al. Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage. J Bone Joint Surg. 1994;76:579-592.
21. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284: 143-147.
22. Phinney DG, Prockop DJ. Concise review: mesenchymal stem/ multipotent stromal cells: the state of transdifferentiation and modes of tissue repair-current views. Stem Cells. 2007;25: 2896-2902.
23. Chamberlain G, Fox J, Ashton B, Middleton J. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells. 2007;25:2739-2749.
24. Sensebe L, Krampera M, Schrezenmeier H, Bourin P, Giordano R. Mesenchymal stem cells for clinical application. Vox Sang. 2010;98:93-107.
25. Montesinos JJ, Flores-Figueroa E, Castillo-Medina S, et al. Human mesenchymal stromal cells from adult and neonatal sources: comparative analysis of their morphology, immuno-phenotype, differentiation patterns and neural protein expression. Cytotherapy. 2009;11:163-176.
26. Lu LL, Liu YJ, Yang SG, et al. Isolation and characterization of human umbilical cord mesenchymal stem cells with hemato-poiesis-supportive function and other potentials. Haemato-logica. 2006;91:1017-1026.
27. Friedenstein AJ, Chailakhyan RK, Latsinik NV, Panasyuk AF, Keiliss-Borok IV. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues: cloning in vitro and retransplantation in vivo. Transplantation. 1974;17:331-340.
28. Macmillan ML, Blazar BR, DeFor TE, Wagner JE. Transplantation of ex-vivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord blood: results of a phase I-II clinical trial. Bone Marrow Transplant. 2009;43: 447-454
29. Fang B, Song Y, Li N, Li J, Zhao RC. Cotransplantation of haploidentical mesenchymal stem cells to reduce the risk of graft failure in a patient with refractory severe aplastic anemia. Acta Haematol. 2008;119:162-165.
30. LaBarge MA, Blau HM. Biological progression from adult bone marrow to mononucleate muscle stem cell to multinucleate muscle fiber in response to injury. Cell. 2002;111:589-601.
31. Liu ZJ, Zhuge Y, Velazquez OC. Trafficking and differentiation of mesenchymal stem cells. J Cell Biochem. 2009;106:984-991.
32. Kyriakou C, Rabin N, Pizzey A, Nathwani A, Yong K. Factors that influence short-term homing of human bone marrow-derived mesenchymal stem cells in a xenogeneic animal model. Haematologica. 2008;93:1457-1465.
33. Ye J, Yao K, Kim JC. Mesenchymal stem cell transplantation in a rabbit corneal alkali burn model: engraftment and involvement in wound healing. Eye (Lond). 2006;20:482-490.
34. Campagnoli C, Roberts IA, Kumar S, et al. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood. 2001;98:2396-2402.
35. Gotherstrom C, West A, Liden J, et al. Difference in gene expression between human fetal liver and adult bone marrow mesenchymal stem cells. Haematologica. 2005;90:1017-1026.
36. Lai RC, et al. Derivation and characterization of human fetal MSCs: an alternative cell source for large-scale production of cardioprotective microparticles. J Mol Cell Cardiol. 2010;48: 1215-1224.
37. In 't Anker PS, Noort WA, Scherjon SA, et al. Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential. Haema-tologica. 2003; 88:845-852.
38. Butler TK, Dua HS, Edwards R, Lowe JS. In vitro model of infectious crystalline keratopathy: tissue architecture determines pattern of microbial spread. Invest Ophthalmol Vis Sci. 2001;42:1243-1246.
39. Jones DRE, Anderson EM, Evans AA, Liu DTY. Long-term storage of human fetal hematopoietic progenitor cells and their subsequent reconstitution-implications for in utero transplantation. Bone Marrow Transplant. 1995;16:297-301.
40. Ruger BM, Breuss J, Hollemann D, et al. Vascular morphogenesis by adult bone marrow progenitor cells in three-dimensional fibrin matrices. Differentiation. 2008;76:772-783.
41. In't Anker PS, Scherjon SA, Kleijburg-van der Keur C, et al. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells. 2004;22:1338-1345.
42. Kim JW, Kim SY, Park SY, et al. Mesenchymal progenitor cells in the human umbilical cord. Ann Hematol. 2004;83:733-738.
43. Janderova L, McNeil M, Murrell AN, Mynatt RL, Smith SR. Human mesenchymal stem cells as an in vitro model for human adipogenesis. Obes Res. 2003;11:65-74.
44. Lapi S, Nocchi F, Lamanna R, et al. Different media and supplements modulate the clonogenic and expansion properties of rabbit bone marrow mesenchymal stem cells. BMC Res Notes. 2008;1:53.
45. Joseph A, Powell-Richards AO, Shanmuganathan VA, Dua HS. Epithelial cell characteristics of cultured human limbal explants. Br J Ophthalmol. 2004;88:393-398.
46. Jaroszeski MJ, Radcliff G. Fundamentals of flow cytometry. Mol Biotechnol. 1999;11:37-53.
47. O'Gorman MR, Thomas J. Isotype controls-time to let go? Cytometry. 1999;38:78-80.
48. Sottile V, Halleux C, Bassilana F, Keller H, Seuwen K. Stem cell characteristics of human trabecular bone-derived cells. Bone. 2002;30:699-704.
49. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402-408.
50. Barbaro V, Di Iorio E, Ferrari S, et al. Expression of VSX1 in human corneal keratocytes during differentiation into myofi-broblasts in response to wound healing. Invest Ophthalmol Vis Sci. 2006;47:5243-5250.
51. Dan YY, Riehle KJ, Lazaro C, et al. Isolation of multipotent progenitor cells from human fetal liver capable of differentiating into liver and mesenchymal lineages. Proc Natl Acad Sci U S A. 2006;103:9912-9917.
52. Kaiser S, Hackanson B, Follo M, et al. BM cells giving rise to MSC in culture have a heterogeneous CD34 and CD45 phenotype. Cytotherapy. 2007;9:439-450.
53. Soncini M, Vertua E, Gibelli L, et al. Isolation and characterization of mesenchymal cells from human fetal membranes. J Tissue Eng Regen Med. 2007;1:296-305.
54. Longobardi L, O'Rear L, Aakula S, et al. Effect of IGF-I in the chondrogenesis of bone marrow mesenchymal stem cells in the presence or absence of TGF-beta signaling. J Bone Miner Res. 2006;21:626-636.
55. Kawakami Y, Tsuda M, Takahashi S, et al. Transcriptional coactivator PGC-1alpha regulates chondrogenesis via association with Sox9. Proc Natl Acad Sci U S A. 2005;102:2414- 2419.
56. Bosnakovski D, Mizuno M, Kim G, et al. Chondrogenic differentiation of bovine bone marrow mesenchymal stem cells (MSCs) in different hydrogels: influence of collagen type II extracellular matrix on MSC chondrogenesis. Biotechnol Bioeng. 2006;93:1152-1163.
57. Sekiya I, Vuoristo JT, Larson BL, Prockop DJ. In vitro cartilage formation by human adult stem cells from bone marrow stroma defines the sequence of cellular and molecular events during chondrogenesis. Proc Natl Acad Sci U S A. 2002;99: 4397-4402.